Skip to main content

Table 1 Funding for biomedical research projects by disease in Gabon between 2005 and 2015

From: Funding patterns for biomedical research and infectious diseases burden in Gabon

Disease

DALYs (Number)

No of funded projects

Total funding amount

Yearly median (IQR)

Malaria

487,949

40 (51.9%)

14,309,712 € (70.2%)

99,000 € (39000–317,000)

Helminthiasis

23,481

12 (15.6%)

2,737,087 € (13.4%)

170,000 € (16000–333,000)

TB

278,479

8 (10.4%)

1,278,284 € (6.3%)

83,000 € (51000–224,000)

Viral diseasesa

1272

2 (2.6%)

1,257,413 € (6.2%)

629,000 € (434000–823,000)

HIV

1,343,268

6 (7.8%)

342,661 € (1.7%)

70,000 € (23000–86,000)

Bacterial diseasesb

 

4 (5.2%)

327,935 € (1.6%)

55,000 € (8000–129,000)

Otherc

71,953

5 (6.5%)

128,866 € (0.6%)

7000 € (6000–53,000)

TOTAL

2,206,402

68 (100%)

20,381,960 € (100%)

 
  1. a Dengue and Ebola hemorrhagic fever
  2. b Helicobacter pylori, Streptococcus, and S. aureus
  3. c Food allergy, fever without source (FWS), hematology, chronic obstructive pulmonary disease (COPD), and hemosporidic parasites and zoonotic viruses